1. Home >
  2. Investors >
  3. Growth Capital Firm >
  4. United States >
  5. California >
  6. Vivo Capital >
  7. M&A

Vivo Capital Mergers & Acquisitions

Vivo Capital M&A Summary

In the last 3 years, Vivo Capital has invested in 1 company.

In the last 3 years, Vivo Capital has exited 3 companies. The Firm’s most common exit type is ipo (77%). Vivo Capital’s largest (disclosed) exit occurred in 2022 when it sold Sierra Oncology for $2.9B.

Sign-up to view Vivo Capital’s full profile and discover more mega-sized growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity46
    • M&A Buy Activity29
    • M&A Sell Activity17
  • M&A Buy/Sell Connections11

Vivo Capital

Vivo Capital LLC

192 Lytton Avenue,
Palo Alto, California 94301
United States
(650) 688-0818
www.vivocapital.com
info@vivocapital.com

All (46) Buy (29) Sell (17)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-03-21 Visen Pharma · Life Science
Shanghai, China · www.visenpharma.com

Visen Pharma is a biopharmaceutical company focused on endocrine-related treatments. It is committed to providing more humane and innovative therapies to enable endocrine patients to enjoy better treatment processes and efficacy, achieving their desired lives. Visen Pharma was founded in 2018 and is based in Shanghai, China.

- IPO -

Ascendis Pharma

HBM Partners PE

Vivo Capital PE

-

Try Mergr Free — See This and 221,398+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal